Increased CD127+ and decreased CD57+ T cell expression levels in HIV-infected patients on NRTI-sparing regimens.

Alejandro Gonzalez-SernaS Ferrando-MartinezL Tarancon-DiezR S De Pablo-BernalB Dominguez-MolinaJ L JiménezM Á Muñoz-FernándezM LealE Ruiz-Mateos

Published in: Journal of translational medicine (2017)

The implementation of NRTI-sparing regimens, with a favourable profile in CD127 and CD57 T-cell expression, could benefit cART-patients. These results could have potential implications in a decrease in the number of Non-AIDS events.

Keyphrases

hiv infected patients
poor prognosis
antiretroviral therapy
end stage renal disease
primary care
chronic kidney disease
healthcare
robot assisted
binding protein
prognostic factors
long non coding rna
risk assessment
patient reported outcomes
minimally invasive